These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 28050350)
41. Characterization of pigmented granules in minocycline-induced cutaneous pigmentation: observations using fluorescence microscopy and high-performance liquid chromatography. Okada N; Sato S; Sasou T; Aoyama M; Nishida K; Yoshikawa K Br J Dermatol; 1993 Oct; 129(4):403-7. PubMed ID: 8217753 [TBL] [Abstract][Full Text] [Related]
42. Minocycline-induced pigmentation occurring in two sisters. Eedy DJ; Burrows D Clin Exp Dermatol; 1991 Jan; 16(1):55-7. PubMed ID: 1827369 [TBL] [Abstract][Full Text] [Related]
43. Minocycline-induced hyperpigmentation masquerading as alkaptonuria in individuals with joint pain. Suwannarat P; Phornphutkul C; Bernardini I; Turner M; Gahl WA Arthritis Rheum; 2004 Nov; 50(11):3698-701. PubMed ID: 15529343 [TBL] [Abstract][Full Text] [Related]
44. Oral presentation of minocycline-induced black bone disease. Odell EW; Hodgson RP; Haskell R Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Apr; 79(4):459-61. PubMed ID: 7614206 [TBL] [Abstract][Full Text] [Related]
45. The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population. Roberts G; Capell HA J Rheumatol; 2006 Jul; 33(7):1254-7. PubMed ID: 16758512 [TBL] [Abstract][Full Text] [Related]
46. Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence. Böhm M; Schmidt PF; Lödding B; Uphoff H; Westermann G; Luger TA; Bonsmann G; Metze D Am J Dermatopathol; 2002 Aug; 24(4):345-50. PubMed ID: 12142617 [TBL] [Abstract][Full Text] [Related]
47. Out of the Blue: A Case of Blue Subungual Discoloration Associated with Prolonged Tetracycline Use. Ahmad Y; Boutros H; Hanna K Cureus; 2020 Apr; 12(4):e7810. PubMed ID: 32467786 [TBL] [Abstract][Full Text] [Related]
48. Doxycycline-Associated Hyperpigmentation: A Case Report and Literature Review. Afrin A; Cohen PR Cureus; 2022 Apr; 14(4):e23754. PubMed ID: 35509754 [TBL] [Abstract][Full Text] [Related]
49. Minocycline-induced pigmentation. Incidence, prevention and management. Eisen D; Hakim MD Drug Saf; 1998 Jun; 18(6):431-40. PubMed ID: 9638388 [TBL] [Abstract][Full Text] [Related]
50. Complete resolution of minocycline pigmentation following a single treatment with non-ablative 1550-nm fractional resurfacing in combination with the 755-nm Q-switched alexandrite laser. Vangipuram RK; DeLozier WL; Geddes E; Friedman PM Lasers Surg Med; 2016 Mar; 48(3):234-7. PubMed ID: 26718463 [TBL] [Abstract][Full Text] [Related]
51. Minocycline-induced pigmentation at sites of cutaneous inflammation. Fenske NA; Millns JL; Greer KE JAMA; 1980 Sep; 244(10):1103-6. PubMed ID: 6447805 [TBL] [Abstract][Full Text] [Related]
52. Diffuse cutaneous hyperpigmentation due to tigecycline or polymyxin B. Knueppel RC; Rahimian J Clin Infect Dis; 2007 Jul; 45(1):136-8. PubMed ID: 17554719 [No Abstract] [Full Text] [Related]
53. Hydroxyurea-induced hyperpigmentation with iron deposition. Lee KP; Vangipuram RK; Klimas NK; Sanyal S; Koshelev MV Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735009 [TBL] [Abstract][Full Text] [Related]